Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Klaus Pugner"'
Autor:
Kate L. Lapane, Susan A. Oliveria, Klaus Pugner, Allan Z. Safferman, Gilbert L'Italien, Rosa Liperoti, William H. Carson
Publikováno v:
Pharmacoepidemiology and Drug Safety. 15:763-774
Purpose The objective of this study was to quantify rates of adverse events in a high-risk multi-morbid population of institutionalized patients with Alzheimer's disease (AD). Methods We conducted a retrospective cohort study among nursing home resid
Publikováno v:
British Journal of Psychiatry. 184:509-516
BackgroundSeveral factors are thought to influence resource use and costs in treating schizophrenia.AimsTo assess the relative impact of non-adherence and other factors associated with resource use and costs incurred by people with schizophrenia.Meth
Autor:
Klaus Pugner
Publikováno v:
British Journal of Healthcare Management. 4:4-7
This article compares the British and German health care systems — examining where the concept of governance fits in the latter and whether there are any lessons to be learnt from the German approach.
Autor:
Tohru Sawada, Robyn I. Stone, Avi Dor, Curtis J. Henke, Anders Wimo, Serge Gauthier, Bernie J. O'Brien, Howard Feldman, Ashoke Bhattacharjya, Suzanne Hill, Klaus Pugner, Meryl Brod, Peter J. Whitehouse, Vera Mastey, Daniel Shostak, Bengt Winblad, Françoise Forette, Peter J. Neumann, Joel W. Hay, Mary Sano, Henry Brodaty
Publikováno v:
Karolinska Institutet
The First International Pharmacoeconomic Conference on Alzheimer's Disease (AD) was held in Amsterdam in July 1998. The meeting was held under the auspices of the International Working Group for Harmonization of Dementia Drug Guidelines (http://demen
Publikováno v:
International clinical psychopharmacology. 18(4)
Data of prescribing practices for antipsychotics are of great interest with respect to quality of care. Consequently, we analysed all prescriptions under the statutory health insurance redeemed at pharmacies in Southern Germany between July 1999 and